| 1 |
Venlafaxine in management of hot flashes in survivors of breast cancer: a randomised controlled trial
Charles L. Loprinzi, John W. Kugler, Jeff A Sloan et al. · The Lancet
|
Dec 2000 |
739 |
| 2 |
Dronabinol Versus Megestrol Acetate Versus Combination Therapy for Cancer-Associated Anorexia: A North Central Cancer Treatment Group Study
Aminah Jatoi, Harold E. Windschitl, Charles L. Loprinzi et al. · Journal of Clinical Oncology
|
15 Jan 2002 |
364 |
| 3 |
Efficacy of gabapentin in the management of chemotherapy‐induced peripheral neuropathy
Ravi D. Rao, John C. Michalak, Jeff A. Sloan et al. · Cancer
|
12 Sep 2007 |
362 |
| 4 |
Neoadjuvant 5-FU or Capecitabine Plus Radiation With or Without Oxaliplatin in Rectal Cancer Patients: A Phase III Randomized Clinical Trial
Carmen Joseph Allegra et al. · JNCI Journal of the National Cancer Institute
Open access |
14 Sep 2015 |
331 |
| 5 |
An Eicosapentaenoic Acid Supplement Versus Megestrol Acetate Versus Both for Patients With Cancer-Associated Wasting: A North Central Cancer Treatment Group and National Cancer Institute of Canada Collaborative Effort
Aminah Jatoi, Kendrith M. Rowland, Charles L. Loprinzi et al. · Journal of Clinical Oncology
|
15 Jun 2004 |
299 |
| 6 |
A double-blind, placebo-controlled trial of a topical treatment for chemotherapy-induced peripheral neuropathy: NCCTG trial N06CA
Debra L. Barton, Edward J. Wos, Rui Qin et al. · Supportive Care in Cancer
Open access |
24 May 2010 |
255 |
| 7 |
Phase III evaluation of nortriptyline for alleviation of symptoms of cis-platinum-induced peripheral neuropathy
Julie E. Hammack, John C. Michalak, Charles L. Loprinzi et al. · Pain
|
Jul 2002 |
231 |
| 8 |
Pilot study of Panax quinquefolius (American ginseng) to improve cancer-related fatigue: a randomized, double-blind, dose-finding evaluation: NCCTG trial N03CA
Debra L. Barton, Gamini S. Soori, Brent A. Bauer et al. · Supportive Care in Cancer
Open access |
5 May 2009 |
216 |
| 9 |
Anastrozole versus tamoxifen in postmenopausal women with ductal carcinoma in situ undergoing lumpectomy plus radiotherapy (NSABP B-35): a randomised, double-blind, phase 3 clinical trial
Richard G. Margolese, Reena S. Cecchini, Thomas B. Julian et al. · The Lancet
Open access |
15 Dec 2015 |
199 |
| 10 |
Efficacy of lamotrigine in the management of chemotherapy‐induced peripheral neuropathy
Ravi D. Rao, Patrick J. Flynn, Jeff A. Sloan et al. · Cancer
|
21 Apr 2008 |
195 |
| 11 |
Phase III, Randomized, Double-Blind, Placebo-Controlled Study of Long-Acting Methylphenidate for Cancer-Related Fatigue: North Central Cancer Treatment Group NCCTG-N05C7 Trial
Amanda R. Moraska, Amit Sood, Shaker R. Dakhil et al. · Journal of Clinical Oncology
Open access |
13 Jul 2010 |
173 |
| 12 |
The use of vitamin E for the prevention of chemotherapy-induced peripheral neuropathy: results of a randomized phase III clinical trial
Lisa A. Kottschade, Jeff A. Sloan, Miroslaw A. Mazurczak et al. · Supportive Care in Cancer
Open access |
9 Oct 2010 |
173 |
| 13 |
Use of letrozole after aromatase inhibitor-based therapy in postmenopausal breast cancer (NRG Oncology/NSABP B-42): a randomised, double-blind, placebo-controlled, phase 3 trial
Eleftherios P. Mamounas, Hanna Bandos, Barry C. Lembersky et al. · The Lancet Oncology
Open access |
30 Nov 2018 |
170 |
| 14 |
Long-term results of a phase III trial comparing once-daily radiotherapy with twice-daily radiotherapy in limited-stage small-cell lung cancer
Steven E. Schild, James A. Bonner, Thomas G. Shanahan et al. · International Journal of Radiation Oncology*Biology*Physics
|
Jul 2004 |
168 |
| 15 |
Further data supporting that paclitaxel‐associated acute pain syndrome is associated with development of peripheral neuropathy
Brandi Reeves, Shaker R. Dakhil, Jeff A. Sloan et al. · Cancer
Open access |
13 Mar 2012 |
162 |
| 16 |
A phase II trial of imatinib (ST1571) in patients with c-kit expressing relapsed small-cell lung cancer: a CALGB and NCCTG study
Grace Kho Dy, Antonius Arthur Miller, Sumithra J. Mandrekar et al. · Annals of Oncology
Open access |
9 Aug 2005 |
150 |
| 17 |
A placebo‐controlled double blind trial of etanercept for the cancer anorexia/weight loss syndrome
Aminah Jatoi, Shaker R. Dakhil, Phuong Nguyen et al. · Cancer
Open access |
2 Aug 2007 |
138 |
| 18 |
Epratuzumab with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy in patients with previously untreated diffuse large B-cell lymphoma
Ivana N. Micallef, Matthew J. Maurer, Gregory A. Wiseman et al. · Blood
Open access |
15 Jun 2011 |
138 |
| 19 |
Two Concurrent Phase II Trials of Paclitaxel/Carboplatin/Trastuzumab (Weekly or Every-3-Week Schedule) as First-Line Therapy in Women with HER2-Overexpressing Metastatic Breast Cancer: NCCTG Study 983252
Edith A. Perez, Vera Jean Suman, Kendrith M. Rowland et al. · Clinical Breast Cancer
|
Dec 2005 |
137 |
| 20 |
Prognostic factors for hyperdiploid-myeloma: effects of chromosome 13 deletions and IgH translocations
Wee Joo Chng, Rafael Santana-Dávila, Scott A. Van Wier et al. · Leukemia
|
2 Mar 2006 |
137 |
| 21 |
The relationship between numbness, tingling, and shooting/burning pain in patients with chemotherapy-induced peripheral neuropathy (CIPN) as measured by the EORTC QLQ-CIPN20 instrument, N06CA
Sherry L. Wolf, Debra L. Barton, Rui Qin et al. · Supportive Care in Cancer
Open access |
12 Apr 2011 |
126 |
| 22 |
Randomized Phase II Study of Two Irinotecan Schedules for Patients With Metastatic Breast Cancer Refractory to an Anthracycline, a Taxane, or Both
Edith A. Perez, David W. Hillman, James A. Mailliard et al. · Journal of Clinical Oncology
Open access |
14 Jul 2004 |
124 |
| 23 |
Does Zinc Sulfate Prevent Therapy-Induced Taste Alterations in Head and Neck Cancer Patients? Results of Phase III Double-Blind, Placebo-Controlled Trial from the North Central Cancer Treatment Group (N01C4)
Michele Y. Halyard, Aminah Jatoi, Jeff A. Sloan et al. · International Journal of Radiation Oncology*Biology*Physics
|
29 Mar 2007 |
119 |
| 24 |
Phase III Comparison of Depomedroxyprogesterone Acetate to Venlafaxine for Managing Hot Flashes: North Central Cancer Treatment Group Trial N99C7
Charles L. Loprinzi, Ralph Levitt, Debra L. Barton et al. · Journal of Clinical Oncology
|
27 Feb 2006 |
118 |
| 25 |
Outcomes Among African-American/Non-African-American Patients With Advanced Non-Small-Cell Lung Carcinoma: Report From the Cancer and Leukemia Group B
A. William Blackstock, James E. Herndon, Electra D. Paskett et al. · JNCI Journal of the National Cancer Institute
|
20 Feb 2002 |
108 |
| 26 |
A prognostic model for advanced stage nonsmall cell lung cancer
Sumithra J. Mandrekar, Steven E. Schild, Shauna L. Hillman et al. · Cancer
|
17 Jul 2006 |
108 |
| 27 |
Evaluation of shark cartilage in patients with advanced cancer
Charles L. Loprinzi, Ralph Levitt, Debra L. Barton et al. · Cancer
|
24 May 2005 |
97 |
| 28 |
Phase III trial comparing chemotherapy plus once-daily or twice-daily radiotherapy in Stage III non-small-cell lung cancer 1 1This study was conducted as a collaborative trial of the North Central Cancer Treatment Group and Mayo Clinic. Additional participating institutions included Cedar Rapids Oncology Project CCOP, Cedar Rapids, IA; Meritcare Hospital CCOP, Fargo, ND; Sioux Community Cancer Con
Steven E. Schild, Philip J. Stella, Susan Michelle Geyer et al. · International Journal of Radiation Oncology*Biology*Physics
Open access |
Oct 2002 |
93 |
| 29 |
Results of combined‐modality therapy for limited‐stage small cell lung carcinoma in the elderly
Steven E. Schild, Philip J. Stella, Burke J. Brooks et al. · Cancer
Open access |
25 Apr 2005 |
87 |
| 30 |
A phase II study of paclitaxel plus carboplatin as first-line chemotherapy for women with metastatic breast carcinoma
Edith A. Perez, David W. Hillman, Philip J. Stella et al. · Cancer
Open access |
2000 |
86 |
| 31 |
Patient-reported outcomes with anastrozole versus tamoxifen for postmenopausal patients with ductal carcinoma in situ treated with lumpectomy plus radiotherapy (NSABP B-35): a randomised, double-blind, phase 3 clinical trial
Patricia A. Ganz, Reena S. Cecchini, Thomas B. Julian et al. · The Lancet
Open access |
16 Dec 2015 |
79 |
| 32 |
Mortality associated with daily bolus 5‐fluorouracil/leucovorin administered in combination with either irinotecan or oxaliplatin
Thierry Delaunoit, Richard M. Goldberg, Daniel J. Sargent et al. · Cancer
Open access |
6 Oct 2004 |
78 |
| 33 |
Multi‐institutional, randomized, double‐blind, placebo‐controlled trial to assess the efficacy of a mucoadhesive hydrogel (MuGard) in mitigating oral mucositis symptoms in patients being treated with chemoradiation therapy for cancers of the head and neck
Ron R. Allison, Aaron A. Ambrad, Youssef Arshoun et al. · Cancer
Open access |
11 Feb 2014 |
77 |
| 34 |
Gemcitabine and oxaliplatin for metastatic pancreatic adenocarcinoma: a North Central Cancer Treatment Groupphase II study
Steven R. Alberts, P. Townley, Richard M. Goldberg et al. · Annals of Oncology
Open access |
20 Mar 2003 |
70 |
| 35 |
Results of a Phase II Study of High-Dose Thoracic Radiation Therapy With Concurrent Cisplatin and Etoposide in Limited-Stage Small-Cell Lung Cancer (NCCTG 95-20-53)
Steven E. Schild, James A. Bonner, Shauna L. Hillman et al. · Journal of Clinical Oncology
|
18 Jul 2007 |
69 |
| 36 |
Phase III randomized, double-blind study of maintenance CAI or placebo in patients with advanced non-small cell lung cancer (NSCLC) after completion of initial therapy (NCCTG 97-24-51)
Elizabeth Anne Johnson, Randolph S. Marks, Sumithra J. Mandrekar et al. · Lung Cancer
|
6 Dec 2007 |
69 |
| 37 |
The use of Ginkgo biloba for the prevention of chemotherapy-related cognitive dysfunction in women receiving adjuvant treatment for breast cancer, N00C9
Debra L. Barton, Kelli N. Burger, Paul J. Novotny et al. · Supportive Care in Cancer
Open access |
12 Nov 2012 |
65 |
| 38 |
A randomized Phase II trial of two dosage levels of letrozole as third-line hormonal therapy for women with metastatic breast carcinoma
James N. Ingle, PATRICIA A. JOHNSON, Vera Jean Suman et al. · Cancer
Open access |
15 Jul 1997 |
64 |
| 39 |
Pretreatment Quality of Life Is an Independent Prognostic Factor for Overall Survival in Patients with Advanced Stage Non-small Cell Lung Cancer
Yingwei Qi, Steven E. Schild, Sumithra J. Mandrekar et al. · Journal of Thoracic Oncology
Open access |
Sep 2009 |
64 |
| 40 |
A randomized trial of tamoxifen alone or combined with octreotide in the treatment of women with metastatic breast carcinoma
James N. Ingle, Vera Jean Suman, Carl G. Kardinal et al. · Cancer
Open access |
15 Mar 1999 |
62 |
| 41 |
Comparison of nicotine patch alone versus nicotine nasal spray alone versus a combination for treating smokers: A minimal intervention, randomized multicenter trial in a nonspecialized setting
Gary A. Croghan, Jeff A. Sloan, Ivana T. Croghan et al. · Nicotine & Tobacco Research
|
2003 |
60 |
| 42 |
A phase II study of cetuximab and radiation in elderly and/or poor performance status patients with locally advanced non-small-cell lung cancer (N0422)
Aminah Jatoi, Steven E. Schild, Nathan R. Foster et al. · Annals of Oncology
Open access |
22 Jun 2010 |
56 |
| 43 |
Docetaxel and capecitabine in patients with metastatic adenocarcinoma of the stomach and gastroesophageal junction: a phase II study from the North Central Cancer Treatment Group
Karin F. Giordano, Aminah Jatoi, Philip J. Stella et al. · Annals of Oncology
Open access |
24 Feb 2006 |
51 |
| 44 |
Phase II trial of oral vinorelbine for the treatment of metastatic breast cancer in patients ≥65 years of age: an NCCTG study
Mansoina Baweja, Vera Jean Suman, Tom R. Fitch et al. · Annals of Oncology
Open access |
7 Mar 2006 |
39 |
| 45 |
A Phase II Trial of Docetaxel and CPT-11 in Patients with Metastatic Adenocarcinoma of the Esophagus, Gastroesophageal Junction, and Gastric Cardia
Aminah Jatoi, Marisa Tria Tirona, Steven S. Cha et al. · International Journal of Gastrointestinal Cancer
|
2002 |
34 |
| 46 |
Patient Assessment of Bowel Function During and After Pelvic Radiotherapy: Results of a Prospective Phase III North Central Cancer Treatment Group Clinical Trial
Michael G. Haddock, Jeff A. Sloan, John William Bollinger et al. · Journal of Clinical Oncology
|
30 Mar 2007 |
33 |
| 47 |
Ploidy status rarely changes in myeloma patients at disease progression
Wee Joo Chng, Jerry M. Winkler, Philip R. Greipp et al. · Leukemia Research
|
19 Aug 2005 |
33 |
| 48 |
Phase II Study of Gemcitabine Plus Cisplatin in Patients With Metastatic Breast Cancer
Patrick A. Burch, James A. Mailliard, David W. Hillman et al. · American Journal of Clinical Oncology
|
31 Mar 2005 |
31 |
| 49 |
Weekly Carboplatin and Paclitaxel in Elderly Non–Small-Cell Lung Cancer Patients (≥65 Years of Age)
Aminah Jatoi, Philip J. Stella, Shauna H. Hillman et al. · American Journal of Clinical Oncology
|
Oct 2003 |
30 |
| 50 |
Gemcitabine and oxaliplatin for patients with advanced or metastatic pancreatic cancer: a North Central Cancer Treatment Group (NCCTG) phase I study
Steven R. Alberts, P. Townley, Richard M. Goldberg et al. · Annals of Oncology
Open access |
Apr 2002 |
27 |